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Abstract Progression of colon cancer from microadenoma
to macroscopic tumors is coupled to augmentation of
canonical Wnt signaling. We recently reported that tumor
associated macrophages, through interleukin 1β (IL-1β)
dependent phosphorylation of GSK3β,p r o m o t eW n t
signaling in colon cancer cells, demonstrating that proin-
flammatory cytokines can enhance TCF4/β-catenin tran-
scriptional activity in tumor cells. Here we investigated the
pathway whereby IL-1β inactivates GSK3β and promotes
Wnt signaling in colon cancer cells. We showed that normal
human monocytes, THP1 macrophages and IL-1 failed to
induce Wnt signaling in tumor cells expressing dominant
negative IκB (dnIκB), demonstrating that macrophages and
IL-1 activate Wnt signaling in a NF-κB-dependent manner.
NF-κB activity was required for macrophages and IL-1 to
activate PDK1 and AKT in tumor cells and thereby inhibit
GSK3β activity. Consistently, dominant negative AKT
(dnAKT), or pharmacological inhibition of AKT in tumor
cells, prevented macrophage/IL-1 mediated phosphoryla-
tion of GSK3β, activation of Wnt signaling, and induction
of c-jun and c-myc, confirming that macrophages and IL-1
promote Wnt signaling in an AKT dependent manner.
Finally, we showed IL-1 and macrophages failed to
promote growth of colon cancer cells with impaired NF-
κB or AKT signaling, confirming the requirement for NF-
κB and AKT activation for the protumorigenic activity of
tumor associated macrophages. Thus, we showed that IL-1
and tumor associated macrophages activate NF-κB-
dependent PDK1/AKT signaling in tumor cells, and thereby
inactivate GSK3β, enhance Wnt signaling and promote
growth of colon cancer cells, establishing a novel molecular
link between inflammation and tumor growth.
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Introduction
Tumor associated macrophages (TAMs) are derived from
circulating monocytes which, upon recruitment to the tumor
microenvironment, polarize and acquire several properties
of M2 macrophages [1, 2]. The tumor microenvironment
therefore “educates” macrophages to orchestrate conditions
that support tumor progression and promote metastasis and
angiogenesis [3].
We recently demonstrated that colon cancer cells
stimulate normal human monocytes and THP1 macro-
phages to release IL-1β, and showed that IL-1β is
sufficient to induce canonical Wnt signaling and to promote
growth of colon cancer cells through inactivation of
GSK3β in the epithelial cells, establishing a previously
unknown link among inflammation, IL-1β, Wnt signaling
and growth of colon cancer cells (Kaler et al, in press).
Macrophages/IL-1β induced Wnt signaling in a panel of
colon cancer cell lines, including HCT116, Hke-3, SW480
and RKO cells (not shown). It remains to be determined
whether macrophages/IL-1β regulate the expression and
the activity of Wnt ligands, Wnt receptors or Wnt
inhibitors, however we showed that macrophages provoked
phosphorylation of GSK3β, stabilized β-catenin and
enhanced TCF4-dependent gene activation and the expres-
sion of Wnt target genes in tumor cells. In this regard, β-
catenin translocation is often detected at the invasive front
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with the hypothesis that surrounding tissue at the invasion
front provides soluble factors that promote nuclear translo-
cation of β-catenin in tumor cells and thus drive tumor
progression. Although increased density of TAMs (tumor
associated macrophages) is associated with poor prognosis
in breast, prostate, bladder and cervical cancer [6–11], there
are contrasting reports regarding the prognostic significance
of macrophage infiltration in colon cancer [12–14]. Our
findings support a protumorigenic role of tumor associated
macrophages in colon cancer, and suggest that they
promote tumor growth, at least in part, through secretion
of IL-1β.
IL-1β is a proinflammatory cytokine that plays an
important role in inflammation, regulates the immune
response and is abundant at tumor sites [15]. Chemically
induced tumor formation was shown to be significantly
delayed in IL-1β deficient mice and IL-1Ra
−/− mice, which
have excessive levels of IL-1β, display rapid tumor
development and high tumor frequency [15–17]. Con-
sistently, the growth of B16 cell xenografts, and their
spread to lung and liver were reduced in IL-1β
−/− mice
[17, 18] and reduced hepatic metastases were seen in mice
that lack IL-1β converting enzyme (ICE, caspase 1) [18],
confirming that IL-1β can regulate both initiation and the
progression of cancer. The IL-1 signaling pathway is well
characterized and it has been shown that IL-1 recruits
Myd88 to the IL-1 receptor, which connects the receptor
with a downstream kinase, IRAK [19]. A dominant
negative Myd88 inhibits IL-1 induced activation of NF-
κB, a major signaling pathway utilized by IL-1 [19].
Importantly, deficiency in Myd88 has been shown to
significantly attenuate intestinal polyposis in Apc
min/+
mice and to increase their survival [20], demonstrating
that Myd88 dependent signaling critically contributes to
intestinal tumorigenesis. Several inflammatory mediators are
increased in Apc
Min/+ polyps, including IL-1 [20], suggest-
ing that the decreased tumor number in the Apc
Min/+/
Myd88
−/−compound mouse may be due to deficient
signaling by IL-1.
In this study we investigated the pathway whereby
macrophages/IL-1 inactivate GSK3β, promote Wnt signal-
ing and enhance growth of colon cancer cells. NF-κB has
been shown to regulate the survival of tumor cells and to
link inflammation and tumor progression [21–23]. We
showed that macrophages, like IL-1, activate NF-κB
signaling in colon cancer cells, leading to activation of the
AKT pathway. PKB/AKT is a kinase that is activated by
recruitment to the plasma membrane through phosphoryla-
tion on Thr
308 by PDK1 and on Ser
473 by PDK2 [24, 25]. It
has a crucial role in promoting cell survival through
phosphorylation of Bad [26], caspase-9 [27], FKHR [28]
and IKKα [29]. Another important downstream target of
AKT is GSK3β [30], a kinase with a crucial role in Wnt
signaling. The pool of GSK3β that participates in Wnt
signaling is present in a multiprotein complex that includes
axin, β-catenin and APC [31, 32]. In the absence of Wnt
signaling, GSK3β phoshorylates axin, β-catenin and APC,
which targets β-catenin for ubiquitin mediated degradation.
Wnt signaling results in inactivation of GSK3β, which
leads to dephosphorylation of axin, APC and β-catenin
[33]. Unphosphorylated β-catenin is stabilized and trans-
locates to the nucleus, where it binds to members of the
TCF family of transcription factors, and finally stimulates
the expression of target genes such as c-myc, c-jun, CD44
and cox-2 [34].
In this study we established that IL-1 and tumor
associated macrophages inactivate GSK3β and promote
Wnt signaling in tumor cells through NF-κB dependent
activation of PDK1 and AKT. Our data therefore suggest
that inhibitors of the NF-κB and PI3K/AKT pathways,
which are in development as chemotherapeutic agents, may
not only work by inhibiting proliferation and promoting
apoptosis of tumor cells, but may also interrupt the
crosstalk between the tumor cells and stroma and thereby
stall tumor progression.
Experimental Procedures
Cell lines and Coculture Experiments
The HCT116 colorectal carcinoma cell line and its clonal
derivative, Hke-3 cells, which lack the mutant k-Ras allele
[35] were cultured under standard conditions in minimum
essential medium supplemented with 10% fetal calf serum
and antibiotics. The human monocytic cell line, THP1, was
cultured in RPMI medium. Normal human monocytes,
>90% CD14 and CD11c positive and less than 1% anti T
cell receptor positive, were purchased from Astarte Bio-
logics (Redmond, WA). Tumor cells and monocytes/macro-
phages were co-cultured separated by transwell inserts of a
polycarbonate membrane with 0.4 μM pore size, thus
precluding direct cell-cell contact, but permitting the
exchange of soluble factors (Corning Incorporated, Lowell,
MA).
Transient Transfections and Reporter Gene Assay
HCT116 and HKe-3 cells were grown in 12-well plates and
were transiently transfected with 0.5µg of luciferase
reporter plasmids per well using the calcium phosphate
method (Profection mammalian Transfection system, Prom-
ega, Madison, WI). Transfection efficiency was normalized
by co-transfection with pTK-Renilla, and luciferase activity
was determined according to the vendor’s protocol (Dual
Luciferase reporter assay, Promega, Madison, WI). Domi-
70 P. Kaler et al.nant negative IκBα was expressed from a plasmid that codes
for IκBα with serines 32 and 36 mutated to alanine, which
confers resistance to stimulus induced degradation [36].
Plasmids expressing constitutively active AKT, (HA-mdelta
(4-129) PH-AKT), and dominant negative AKT (HA-AKT-
K179M) were provided by Richard Roth [26, 37].
IL-1β and STAT1 were silenced in THP1 macrophages
by transient transfection with 20 nM of siRNAs specific for
IL-1β or STAT1 (Dharmacon, Lafayette, CO) using Lip-
ofectamine LTX (Invitrogen, Carlsbad, CA) as we de-
scribed earlier (Kaler et al, in press, [38]).
Clonogenic Assay
To asses the clonogenic potential of HCT116 and Hke-3
cells and the effect of macrophage-derived factors on their
clonogenic potential, tumor cells were seeded at a density
of 200 or 400 cells per well of a six well plate and were
cultured with THP1 cells or were treated with IL-1 for
4 days. Cells were then washed and grown in complete
media for another 3 days. Colonies were washed with PBS,
fixed and stained with 6% glutaraldehyde and 0.5% crystal
violet for 30 min at room temperature. Colonies were
counted and their average volume determined using Total
Lab 1.1 software (Nonlinear Dynamics, Durham, NC,
USA).
Immunoblotting
Proteins were fractionated by 10% SDS-PAGE and trans-
ferred onto a nitrocellulose membrane. Membranes were
blocked with 5% nonfat dry milk in TBS containing 0.1%
Tween 20 and then incubated with antibodies specific to
pAKT (Ser
473), pAKT (Thr
308), total AKT, pPDK1, p-cRaf,
pGSK3β, active β-catenin, phospho-c-Myc (Thr
58/Ser
62)
(Cell Signaling Technology, Inc. Danvers, MA), β-actin
(Sigma Aldrich, St. Louis, MO), c-Myc, c-Jun (Santa Cruz
Biotechnology Inc., Santa Cruz, CA); HA (Roche Applied
Science, Indianapolis, IN); and IκBα (New England
Biolabs, Ipswich, MA). Bound antibodies were detected
using peroxidase-coupled secondary antibodies, followed
by an enhanced chemiluminescent detection system (Amer-
sham ECL™ western blotting detection kit, Amersham
Biosciences, Piscataway, NJ).
Results
Macrophages/IL-1β Induce Wnt Signaling in a NF-κB
Dependent Manner We recently demonstrated that IL-1β
induces Wnt signaling in colon cancer cells, a novel
signaling pathway for this cytokine (Kaler et al, in press).
We showed that IL-1 failed to induce the expression of
c-jun and c-myc in cells transfected with dnTCF4 (not
shown), confirming that the expression of at least some
IL-1 target genes requires intact Wnt signaling.
We recently showed that colon cancer cells stimulate
normal peripheral blood monocytes and THP1 macro-
phages to release IL-1β (Kaler et al, in press). Consistent
with the IL-1 release, THP1 macrophages increased NF-κB
transcriptional activity in HCT116 cells (Fig. 1A), and
normal peripheral blood monocytes and THP1 cells
induced degradation of IκBα in both HCT116 and Hke-3
colon cancer cell lines (Fig. 1B).
dnTCF4 did not interfere with the ability of THP1
macrophages (Fig. 1A) or IL-1 (Fig. 1C) to induce NF-κB
activity, demonstrating that Wnt signaling does not con-
tribute to IL-1 mediated NF-κB activation. This experiment
also demonstrated that in our system, Wnt/β-catenin
signaling does not inhibit the ability of THP1 macrophages
(Fig. 1A), IL-1 (Fig. 1C), or TNF (not shown) to induce
NF-κB activity, as has been recently reported [39]. As
expected, transfection of HCT116 cells with dnIκB pre-
vented the ability of IL-1 to activate NF-κB (Fig. 1C) and
IL-1 induced Wnt signaling was abolished in cells trans-
fected with dnTCF4 (Fig. 1D).
To determine whether IL-1 activates Wnt signaling in a
NF-κB dependent manner, we transfected HCT116 cells
with the TOP-FLASH and FOP-FLASH reporter vectors in
the presence of dnIκB. In cells transfected with an empty
plasmid (neo), IL-1 induced ~ 3-fold increase in TOP/FOP
activity (Fig. 2A). In contrast, expression of dnIκB
abolished the ability of IL-1β to induce Wnt signaling,
demonstrating that NF-κB activity is required for IL-1 to
induce Wnt signaling (Fig. 2A).
We recently showed that colon cancer cells stimulate
macrophages to release IL-1β (Kaler et al, in press).
Consistent with this, normal human monocytes, precursors
of the tumor associated macrophages, and THP1 macro-
phages were both potent inducers of Wnt signaling in tumor
cells (Fig. 2B). On average, monocytes induced ~4-fold and
~THP1 macrophages ~ 3-fold increase in Wnt activity
(Fig. 2B). However, like IL-1, macrophages failed to induce
Wnt signaling in HCT116 cells transfected with dnIκB
(Fig. 2B), and, as expected, in cells transfected with
dnTCF4 (Fig. 2B). These data established that tumor
associated macropohages induce Wnt signaling in tumor
cells through a NF-κB dependent pathway.
To confirm the requirement of NF-κB activity for IL-1-
induced Wnt/β-catenin signaling, we used antibody that
specifically recognizes the phosphorylated, inactive form of
GSK3β (pGSK3βSer
9) to show that IL-1 and THP1
macrophages failed to inactivate GSK3β in HCT116 cells
expressing dnIκB, and that the levels of active (unphos-
phorylated) β-catenin were significantly reduced in
HCT116 cells with impaired NF-κB signaling (Fig. 2C).
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Tumor Cells Because AKT has been shown to be a
downstream target of NF-κB[ 40], to phosphorylate GSK3β
[30] and to be involved in Wnt signaling [41,42], we next
tested whether macrophages/IL-1 inactivate GSK3β through
activation of the AKT in colon cancer cells. Serum starved
HCT116 cells were either left untreated or were treated with
IL-1 for 30 min, 1 h or 3 h, and cell lysates were examined for
Fig. 1 THP1 macrophages induce NF-κB signaling in HCT116 cells. a
HCT116 cells were transiently transfected with the NF-κB reporter gene
in the absence or the presence of dnTCF4 as indicated, and were
cultured alone or together with THP1 macrophages for 24 h. b HCT116
and Hke-3 cells were co-cultured with normal peripheral blood
monocytes, THP1 macrophages or were treated with IL-1 (5 ng/ml) as
indicated and the levels of IκBα was determined by immunoblotting,
c and d HCT116 cells were transfected with the NF-κB reporter plasmid
(C) or the TOP-FLASH reporter (D) together with an empty plasmid
(neo) or dnIκB or dnTCF4, and were either left untreated, or were
treated with IL-1 as indicated. Cells were also transfected with the FOP-
FLASH reporter plasmid, and the results are presented as the ratio
between TOP-FLASH and FOP-FLASH activity (Fig. 1D)
Fig. 2 IL-1 and macrophages
induce Wnt signaling in a NF-
κB dependent manner. a
HCT116 cells were transiently
transfected with the TOP-
FLASH reporter gene together
with an empty vector (neo), or
dnIκB, and were treated with
IL-1 as indicated. The results are
presented as the ratio between
the TOP-FLASH and FOP-
FLASH activity. b HCT116
cells were transfected with the
TOP-FLASH reporter gene to-
gether with an empty vector
(neo), dnIκB, or dnTCF4 and
were cultured with normal
human monocytes (Mo) or
THP1 macrophages for 24 h. C:
Cell lysates from cells trans-
fected with an empty vector
(neo) or dnIκB were examined
for the expression of pGSK3β
and active β-catenin
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phosphorylated on Ser
473 and Thr
308.A ss h o w ni nF i g .3A,
IL-1 treatment resulted in a rapid phosphorylation of AKT at
both residues. Likewise, PDK1, a kinase responsible for
activation of AKT, was activated by IL-1, and c-raf, a known
target of AKT, was phosphorylated by IL-1 (Fig. 3A). In
contrast, the levels of total AKT and β-actin were not
modulated by the treatment with IL-1.
We showed that, like IL-1β, normal peripheral blood
moncoytes and THP1 macrophages phosphorylate AKT
and inactivate GSK3β in tumor cells (Fig. 3B). Monocytes
were equally potent in inducing PDK1/AKTsignaling when
they were separated from the tumor cells with a cell
impermeable membrane (Fig. 3C), confirming that they
induce PDK1/AKT signaling in tumor cells through a
soluble factor. To determine whether macrophages induce
AKT signaling in tumor cells through IL-1, we co-cultured
HCT116 and HKe-3 cells with THP1 macrophages with
silenced IL-1β or STAT1, which we established is required
for the IL-1 release from macrophages (Kaler et al, in
press). We showed that IL-1 or STAT1 deficient THP1
macrophages failed to phosphorylate AKT or activate
PDK1 in tumor cells (Fig. 3D), confirming that IL-1
mediates AKT dependent inactivation of GSK3β in tumor
cells.
Finally, we showed that IL-1, THP1 macrophages and
peripheral blood monocytes failed to phosphorylate AKT
and PDK1 in tumor cells expressing dnIκB (Fig. 4A, data
not shown), demonstrating that they activate AKT signaling
in a NF-κB dependent manner. The NF-κB and AKT
pathways are known to interact and AKT has been shown
to be either downstream or upstream of NF-κB[ 29, 40]. We
showed that transfection of cells with dnAKT (unlike
transfection with dnIκB) did not impair the ability of
macrophages, IL-1 or TNF to trigger IκBα degradation in
HCT116 cells (Fig. 4B) and did not affect NF-κB
transcriptional activity (data not shown), confirming that
AKT acts downstream of NF-κB. This is consistent with
our finding that macrophages and IL-1 failed to activate
AKT in cells expressing dnIκB (Fig. 4A). The mechanism
whereby NF-κB activates AKT phosphorylation is current-
ly being investigated in the laboratory.
AKT is Required for Macrophage and IL-1 Induced Wnt
Signaling in Tumor Cells To determine whether AKT is
required for IL-1 induced Wnt signaling, we transfected
Fig. 3 IL-1 and macrophages
activate PDK1/AKT. a Serum
starved HCT116 cells were
treated with IL-1 as indicated
and cell lysates were examined
for phosphorylation of AKT,
PDK1, GSK3β, and c-Raf.
b HCT116 cells were cultured
with peripheral blood mono-
cytes (Mo) or THP1 macro-
phages and were examined for
activation of AKT and phos-
phorylation of GSK3β.
c HCT116 cells were cultured
with peripheral blood mono-
cytes either directly, or were co-
cultured using transwell inserts
(0.4 μm size). d HCT116 and
Hke-3 cells were co-cultured
with THP1 macrophages trans-
fected with nontargeting siRNA
(THP1) or siRNA specific for
IL-1 or STAT1. The expression
of pPDK1, pAKT, AKT and
βactin was determined by
immunoblotting
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absence or the presence of dnAKT. The expression of
dnAKT was confirmed by immunoblotting with an anti HA
antibody (Fig. 5C). We showed that the ability of IL-1 to
induce Wnt signaling was abolished in cells transfected
with dnAKT, demonstrating that AKT is required for the
IL-1 mediated Wnt signaling (Fig. 5A). Consistently,
normal peripheral blood monocytes and THP1 macro-
phages failed to induce Wnt signaling in tumor cells that
were transfected with dnAKT (Fig. 5B), confirming that
AKT mediates the crosstalk between tumor cells and
macrophages. Consistent with the inability of IL-1 or
THP1 macrophages to promote Wnt signaling in HCT116
cells transfected with dnAKT, these cells did not respond to
IL-1 or THP1 macrophages with phosphorylation of
GSK3β or activation of β-catenin (Fig. 5C). Finally, we
showed that the expression of a constitutively active AKT
(CA AKT) was sufficient to drive Wnt signaling (Fig. 5D).
We showed previously that macrophages and IL-1
induce the expression of Wnt target genes in tumor cells,
including c-myc (Kaler et al, in press). c-Myc activity is
also regulated at the posttranslational level through GSK3β
mediated inhibitory phosphorylation of c-myc at Thr58, and
ERK activating phosphorylation at Ser62 [43]. We demon-
strated that macrophages and IL-1 induced c-myc phos-
phorylation on Thr58/Ser62 in tumor cells (Fig. 5E),
demonstrating that factors in the tumor microenvironment
also regulate the stability of Myc protein in tumor cells.
The ability of THP1 macrophages and IL-1 to induce the
expression of c-myc and c-jun and to increase c-myc
phosphorylation was abrogated not only in tumor cells
transfected with dnIκB (Fig. 5E), but also in cells trans-
fected with dnAKT (Fig. 5F), confirming the requirement
of AKT for Wnt signaling. The expression of CA AKT was
not sufficient to significantly increase the basal expression
of c-myc or c-jun, but it augmented the responsiveness of
tumor cells to IL-1 and macrophages (Fig. 5F). TNF acted
as a poor inducer of c-myc and c-jun, consistent with its
weaker ability to induce Wnt signaling in HCT116 cells
(not shown).
Altogether, these data established that IL-1/macrophages
promote Wnt signaling and activate Wnt targets through
activation of the NF-κB-dependent AKT signaling.
Pharmacological Inhibition of AKT by LY294002 or
Taxotere Abrogates Wnt Signaling in Tumor Cells To
confirm the requirement of AKT for Wnt signaling, we
tested whether pharmacological inhibition of AKT inter-
feres with the ability of macrophages/IL-1 to promote Wnt
signaling. HCT116 and Hke-3 cells transfected with the
TOP-FLASH reporter vector were cultured with THP1
macrophages and were treated with IL-1 in the absence or
the presence of LY294002 (LY), a specific inhibitor of
PI3K/AKT signaling. While treatment of tumor cells with
LY294002 did not modulate constitutive β-catenin/TCF
driven transcriptional activity, it abrogated the ability of
macrophages and IL-1 to induce Wnt signaling in both
HCT116 and Hke-3 cells (Fig. 6), confirming that macro-
phages/IL-1 promote Wnt signaling in an AKT dependent
manner.
Taxotere is a semi-synthetic analogue of taxol, which has
been approved for the treatment of breast, ovarian, and non-
small cell lung cancer. It inhibits the activity of AKT by
promoting proteasomal degradation of the heat shock
protein 90 (Hsp90) which protects AKT from dephosphor-
ylation by PPA2 [44, 45]. Like LY294002, taxotere did not
affect the basal Wnt signaling in either HCT116 or Hke-3
cells, but it abrogated the ability of macrophages and IL-1
to induce Wnt signaling in tumor cells (Fig. 6). These data
confirmed that AKT mediates macrophages/IL-1 induced
Fig. 4 AKT acts downstream of
NF-κB: a HCT116 cells were
transfected with an empty plas-
mid (neo) or dnIκB and were
cultured with THP1 macro-
phages or were treated with IL-1
as indicated. b HCT116 cells
were transfected with an empty
plasmid (neo), dnIκB, dnAKT
or CA AKT and were treated as
indicated. The levels of pAKT,
pPDK1 and IκBα were deter-
mined by immunoblotting
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biological activity for taxotere.
Tumor Promoting Activity of Macrophages/IL-1 Require
both NF-κB and AKT Signaling in Tumor Cells We showed
that macrophages and IL-1, through their ability to induce
Wnt signaling, promote the clonogenic growth of colon
cancer cells (Kaler et al, in press). Because we established
that macrophages and IL-1 induce Wnt signaling in an NF-
κB dependent manner (Fig. 2), we tested whether inhibition
Fig. 5 AKT is required for IL-1 or macrophage-induced Wnt signaling.
a and b HCT116 cells were transfected with the TOP-FLASH reporter
gene and were co-transfected with an empty vector (neo) or dnAKT as
indicated. Cells were left untreated (CTRL) or were treated with IL-1 or
were co-cultured with normal human peripheral blood monocytes (Mo)
or THP1 macrophages. c Cell lysates from HCT116 cells transfected
with an empty vector (neo) or dnAKT were tested for the expression of
pGSK3β and active β-catenin. The expression of dnAKT was
confirmed by immunoblotting for HA. d HCT116 cells were transfected
with the TOP-FLASH reporter gene together with increasing concen-
trations of an empty vector (neo) or constitutively active AKT (CA
AKT). The expression of CA AKT was confirmed by immunoblotting
for HA (see the inset). E: HCT116 cells were transfected with an empty
plasmid (neo), dnIκB, dnAKT or CA AKT and were cultured with
THP1 macrophages or were treated with IL-1 or TNF for 1 h. The
levels of c-myc, c-myc Thr58/Ser62, c-jun and βactin were determined
by immunoblotting
NF-κB/AKT-dependent activation of Wnt signaling by IL-1 75of NF-κB activity in tumor cells hampers the ability of
macrophages and IL-1 to promote their growth. HCT116
cells were transfected with an empty vector or with dnIκB
and the ability of THP1 macrophages or IL-1 to increase
their clonogenic potential was examined as described in
Material and Methods. As shown in Fig. 7A and B, while
macrophages and IL-1 strongly increased the clonogenic
growth of HCT116 cells transfected with an empty vector
(neo), they failed to promote the growth of HCT116 cells
with impaired NF-κB signaling. Macrophages and IL-1 also
significantly increased the volume of the colonies in
HCT116 cells, which was dependent on NF-κB signaling
in tumor cells as well (Fig. 7B). Similar results were
obtained in Hke-3 cells (not shown).
Since we demonstrated that AKT is downstream of NF-
κB, we next tested whether inhibition of AKT activity in
tumor cells alters their interactions with macrophages.
Macrophages and IL-1 increased both the size and the
number of colonies in HCT116 cells transfected with an
empty vector, but not in cells transfected with dnAKT
(Fig. 7C and D), demonstrating that AKT mediates the
growth promoting activity of macrophages/IL-1. In two
independent experiments, each performed in duplicate, both
HCT116 and Hke-3 cells transfected with dnAKT yielded
colonies with significantly larger volume; the reason for
this increase remains, for now, unknown.
In summary, our data demonstrate that, as tumor cells
recruit normal peripheral blood monocytes to the tumor
microenvironment, they stimulate them to release IL-1β.
We showed that tumor associated macrophages and
recombinant IL-1 exert their protumorigenic activity
through NF-κB/AKT dependent activation of Wnt signal-
ing in tumor cells (Fig. 8), establishing a novel molecular
link among inflammation, Wnt signaling and tumor
progression.
Discussion
We recently reported that macrophages promote growth of
colon cancer cells through IL-1 mediated, STAT1 depen-
dent, activation of Wnt signaling (Kaler et al, in press).
Here we show that peripheral blood monocytes, direct
precursors of the tumor associated macrophages, and IL-1
activate Wnt signaling in tumor cells in a NF-κB/AKT
dependent manner. NF-κB activity is triggered through
activation of the IKK complex by a variety of proinflam-
matory cytokines, including TNF and IL-1, and activation
of NF-κB in tumor cells appears to be a critical molecular
link between inflammation and cancer [21, 46]. Specific
inactivation of NF-κB signaling in intestinal cells dramat-
ically decreased the incidence of intestinal tumors in a
mouse model of colitis associated cancer [22]. Inhibition of
NF-κB has been shown to convert LPS-induced growth of
CT26 mouse colon carcinoma cells into LPS-induced tumor
regression through apoptosis [23], demonstrating that an
active NF-κB signaling in intestinal cells is required for
tumor progression. Malignant cells have been shown to
drive NF-κB activation in TAMs in order to maintain their
immunosuppressive phenotype [47], suggesting that intact
NF-κB signaling in both tumor cells and macrophages is
required for the interaction of tumor cells with tumor
associated macrophages. Here we show that macrophages
a n dI L - 1f a i l e dt oa c t i v a t eA K Ts i g n a l i n g ,i n a c t i v a t e
GSK3β and to induce Wnt signaling in tumor cells with
impaired NF-κB activity. Consistently, macrophages and
IL-1 did not increase the clonogenic growth of colon cancer
cells expressing dnIκB.
We established that NF-κB activity is required for
macrophages and IL-1 to stimulate PDK1 and AKT in
tumor cells, demonstrating that AKT is downstream of
NF-κB signaling. The molecular link between the NF-κB
and PDK1/AKT signaling remains to be determined, but
both IL-1 and TNF have been shown to trigger AKT
activation in a PI3K dependent manner [29, 48]. Several
experiments indicate that AKT and Wnt signaling interact.
It has been recently shown that nuclear AKT inhibits,
whereas membrane tethered AKT stimulates β-catenin
transcriptional activity [42], underscoring a complex nature
Fig. 6 Pharmacological inhibition of AKT by LY294002 or taxotere
in HCT116 (a) and Hke-3 (b) cells inhibits enhanced Wnt signaling in
tumor cells in response to macrophages or IL-1. Cells were transfected
with the TOP-FLASH reporter gene and were cultured with THP1
cells or were treated with IL-1 in the presence of LY or taxotere as
indicated. LY = LY294002 (20 μM), Tax = taxotere (10 nM)
76 P. Kaler et al.of the crosstalk between the canonical Wnt and AKT
signaling pathways. AKT has also been shown to directly
phosphorylate β-catenin at Ser
552, which, in contrast to the
GSK-3β mediated pathway, does not alter β catenin
stability, but promotes its nuclear translocation [41]. Thus,
AKT can activate β-catenin/TCF transcriptional activity
both by indirect stabilization of β-catenin through inhibi-
tion of GSK3β and by direct phoshorylation of β-catenin
which promotes β-catenin nuclear accumulation. We
demonstrated that IL-1 and tumor associated macrophages
inactivate GSK3β in tumor cells, but do not have data to
support a direct phosphorylation of β-catenin by IL-1 or by
tumor associated macrophages.
The ability of macrophages and IL-1 to induce Wnt
signaling and the expression of Wnt target genes, such as
c-myc and c-jun, was abrogated in cells transfected with
dnAKT. Consistently, macrophages and IL-1 failed to
increase the clonogenic growth of tumor cells in the
absence of AKT signaling, demonstrating that macrophages/
IL-1 activate Wnt signaling and exert protumorigenic activity
through a NF-κB/AKT dependent pathway.
Several of our experiments were performed with the
transformed THP1 monocytic cell line, however we have
confirmed that normal peripheral blood monocytes, cells
that are recruited to the tumor microenvironment and
polarize into tumor associated macrophages, also secrete
Fig. 7 NF-κB( a, b)a n dA K T( c, d) mediate the growth promoting
activity of macrophages: HCT116 cells were transfected with an empty
vector (neo), dnIκB, or dnAKT as indicated, and were either cultured
with macrophages or were stimulated with IL-1. The number of
colonies and their volume were determined as described in Material and
Methods. A and C show representative colonies. B: *, p<0.0001, #, p<
0.0001: **,p=0.013, ##, p=0.022, D: *, p=<0.0001, #, p=0.0001: **,
p=0.0003, ##, p=0.00003
NF-κB/AKT-dependent activation of Wnt signaling by IL-1 77IL-1 when stimulated with tumor cells, induce Wnt
signaling and expression of Wnt target genes in tumor
cells and promote tumor growth (Kaler et al, in press). Here
we showed that, like THP1 cells, normal monocytes
promote Wnt signaling in tumor cells through an NF-κB
(Fig. 2B) and AKT (Fig. 5B) dependent pathway.
Abnormal activation of AKT is found in a variety of
human tumors, including colorectal cancer, as a result of
activating mutations of PIK3CA, overexpression of AKT,
the loss of PTEN, or constitutive signaling by Ras [49].
However, it was demonstrated that in epithelial cells mutant
Ras is not sufficient for full activation of the PI3K kinase,
induction of AKT or inactivation of GSK3β [50] and that
co-expression of Ras with PIK3CA is required for AKT
activation and full transformation. Consistently, colorectal
tumors often co-express kRas and PI3KCA mutations [51].
However, despite the fact that HCT116 cells carry both
kRas mutation and the PI3KCA mutation [52], the level of
activated AKT in these cells is rather low (Fig. 3). We
showed that tumor associated macrophages, or IL-1,
significantly increase AKT signaling in HCT116 cells and
inactivate GSK3β, suggesting that inflammatory signals
may substitute for the cooperative mutations during tumor
progression.
A number of studies have established that inflammation
contributes to many types of malignancies, including
colorectal cancer. Consistently, IBD patients have elevated
risk for colorectal cancer, and anti-inflammatory agents
exert chemopreventive activity. Mutations in NOD2 that
have been linked to Crohn’s disease, and therefore to
increased risk of colorectal cancer, are associated with
increased production of IL-1β and increased colonic
inflammation [53]. The role of NF-κB, which is a major
signaling pathway utilized by proinflammatory cytokines,
including IL-1β, in ulcerative colitis and colon cancer has
been established [22]. In this report we present data which
demonstrate that IL-1β-induced NF-κB activation is cou-
pled to Wnt signaling, a major oncogenic pathway which
regulates differentiation and proliferation of intestinal
epithelial cells. Our findings established a direct link
between inflammation and tumor progression, and suggest
a model whereby Wnt driven tumorigenesis is modulated
by IL-1β-dependent signaling from the macrophages
present in the tumor microenvironment.
Colon cancer development/progression can be controlled
by chemopreventive agents, such as nonsteroidal anti-
inflammatory drugs (NSAIDs) and vitamin D. NSAIDs
act through inhibition of COX-2 activity [54] and inhibition
of peroxisome proliferator-activated receptor δ (PPARδ)
[55]. Several NSAIDs, such as sulindac and aspirin, are
also potent inhibitors of NF-κB activity in tumor cells
[56,57]. Because we showed that NF-κB signaling mediates
the interaction of tumor cells with tumor associated macro-
phages, our results suggest that NSAIDs may exert their
chemopreventive activity also by interrupting a crosstalk
between the tumor cells and the tumor associated macro-
phages. We have recently reported that vitamin D, another
potent chemopreventive agent for colon cancer, alters the
ability of macrophages to promote tumor growth through
inhibition of the release of IL-1 from macrophages (Kaler et
Fig. 8 Signaling pathway
whereby tumor associated mac-
rophages promote Wnt signaling
in tumor cells. Peripheral blood
monocytes (Mo) were cultured
with control medium or with
conditioned medium from
HCT116 or Hke-3 cells for 48 h.
As shown here, soluble factor(s)
from HCT116 and Hke-3 cells
induced maturation of normal
peripheral blood monocytes
(Mo), demonstrated by phalloi-
din/DAPI staining, coupled to
the release of IL-1β. IL-1β,
through activation of NF-κB,
induced phosphorylation of
PDK1 and AKT, which inacti-
vates GSK3β, leading to
enhanced β-catenin/TCF4 tran-
scriptional activity, and in-
creased expression of Wnt target
genes in tumor cells, including
c-myc and c-jun
78 P. Kaler et al.al, in press). Likewise, our data suggest that inhibitors of
PI3K/AKT signaling, which are in preclinical and clinical
trials, may also interrupt the crosstalk between the tumor
cells and stroma. Our demonstration that taxotere, an
inhibitor of AKT activity, hampers the ability of macro-
phages to induce Wnt signaling in tumor cells provides
support for such a premise.
Thus, it appears that commonly used chemopreventive
and chemotherapeutic agents can prevent tumor progression
by disrupting the interaction of tumor cells with the tumor
microenvironment, acting either on the tumor cells them-
selves, or on the cells in the tumor microenvironmet.
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